Biotech Co. Names Well-Traveled Former GC As Board Chair
By Sue Reisinger · October 9, 2024, 4:00 PM EDT
Virometix AG, a privately held Swiss biotechnology company developing synthetic vaccines against infectious diseases and cancer, has appointed a globe-trotting former general counsel as chair of its board of directors. ...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login